Document Details

Form
D
Filing Date
Sep 9, 2026
Document Date
Sep 9, 2026
Form Description
Notice of Exempt Offering of Securities
Filing Group
Other
Company
BioLineRx
Issuer
BioLineRx Ltd.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Shape
Potential life-changing treatments are on the way

Each molecule in our development pipeline is carefully selected for its potential ability to improve upon the standard of care, delivering maximum value to patients

Discover our Pipeline